CRITIQUE: Beta Blocker Nasal Spray for Actue Migraine

Mo Med. 2024 Mar-Apr;121(2):102-104.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Intranasal
  • Adrenergic beta-Antagonists* / administration & dosage
  • Adrenergic beta-Antagonists* / therapeutic use
  • Humans
  • Migraine Disorders* / drug therapy
  • Nasal Sprays*

Substances

  • Nasal Sprays
  • Adrenergic beta-Antagonists